Physician Assistant Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Christopher Cornett

Physician Assistant Ventura, CA Physician Assistant

NPI 1952863573 CMS profile 10478744

5720 Ralston St Ste 205, Ventura, CA 93003

Open in the dashboard

General payments

$10,854

435 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Cornett of Ventura, CA is reported in the CMS Open Payments database as having received $10,854 across 435 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,597 133
2024 General $2,687 107
2023 General $3,040 122
2022 General $1,529 73

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Cornett
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Christopher Cornett were reported at $3,597. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Christopher Cornett Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $1,529 $155 $48–$522 $149
2023 $3,040 $167 $52–$557 $160
2024 $2,687 $178 $55–$600 $164
2025 $3,597 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. GlaxoSmithKline, LLC. $1,611 92 payments
  2. AstraZeneca Pharmaceuticals LP $1,459 52 payments
  3. Amgen Inc. $1,130 42 payments
  4. Regeneron Healthcare Solutions, Inc. $1,048 45 payments
  5. Genzyme Corporation $1,043 35 payments
  6. Novartis Pharmaceuticals Corporation $667 26 payments
  7. ALK-Abello, Inc $596 15 payments
  8. Pfizer Inc. $402 19 payments
  9. Blueprint Medicines Corporation $390 10 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $381 20 payments
  11. Other $2,127 79 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $10,659 430 payments
  2. Education $156 3 payments
  3. Consulting Fee $39 2 payments
Products named General payments · program years 2022–2025
  1. NUCALA $1,241 69 payments
  2. DUPIXENT Immunology $1,127 47 payments
  3. TEZSPIRE Inflammation $1,001 41 payments
  4. FASENRA $869 26 payments
  5. DUPIXENT Inflammation And Immunology $820 36 payments
  6. TEZSPIRE Respiratory $515 15 payments
  7. AIRSUPRA $413 12 payments
  8. TRELEGY ELLIPTA $370 23 payments
  9. Orladeyo $307 12 payments
  10. Odactra $296 10 payments
  11. Other $4,832 196 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

435 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record